Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
April 28, 2020 at 08:35 pm IST
Share
Guizhou Salvage Pharmaceutical Co.,Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 2,026.286 million compared to CNY 2,430.806 million a year ago. Operating loss was CNY 1,708.910 million compared to operating Income of CNY 266.133 million a year ago. Net loss was CNY 1,709.715 million compared to net income of CNY 197.329 million a year ago. Basic loss per share from continuing operations was CNY 1.0098 compared to basic earnings per share from continuing operations of CNY 0.1141 a year ago.
Guizhou Chitianhua Co Ltd, formerly Guizhou Salvage Pharmaceutical Co Ltd, is a China-based company mainly engaged in chemical production and pharmaceutical production. The chemical business mainly includes the production and sales of urea, methanol and compound fertilizer. The pharmaceutical manufacturing business mainly includes the production and sales of pharmaceuticals and medical devices. The Company's pharmaceutical products include diabetes drugs, cardiovascular drugs, dermatology drugs, gynecological drugs, digestive system drugs, endocrine drugs, psychotropic drugs, among others. The Company mainly conducts businesses within the domestic market.